Abstract
Hospitalized patients often require thromboprophylaxis to prevent venous thromboembolism. While multiple therapeutic options exist, low molecular weight heparins (LMWHs) are favored for their advantageous pharmacokinetic profile and limited adverse effects [Torres et al. 2010]. Enoxaparin, an LMWH, has been infrequently associated with mild hyperkalemia [Torres et al. 2010; Bengalorkar et al. 2011]. A case of profound hyperkalemia associated with prophylactic enoxaparin is reported.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
